Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 9/2/2025Astellas Accelerates Growth and Innovation in China
  • 9/2/2025Nine First-in-Class Drugs Receive Initial Clinical Approval in China
  • 9/2/2025Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...
  • 9/2/2025China Approved Seven New Drugs in August
  • 9/1/2025BioNTech Launches Phase 1/2 Trial of BNT327 and BNT3212 in Advanced Tu...
  • 9/1/2025Fosun Licenses Accro's TYK2/JAK1 Inhibitor AC-201 in Greater China
  • 9/1/2025Hongcheng Launches Phase II Trial for PD-1/CTLA-4/VEGF TsAb in Advance...
  • 9/1/2025Ennovabio Secures New Financing to Advance Pipeline for Immune and Met...
  • 9/1/2025Novel iPSC-Derived Neural Cell Therapy Shows Promise in SCI Treatment
  • 9/1/2025Convalife's HKEX IPO Application Gets Green Light
  • 9/1/2025Hengrui Seeks NMPA Approval for New Dual-Receptor Obesity Drug HRS9531
  • 8/30/2025Recent Executive Moves
  • 8/30/2025CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib
  • 8/29/2025Eli Lilly Partners with JD Health for Popular Weight-Loss Medicines
  • 8/29/2025Fosun Secures Exclusive Rights to ACCRO's AC-201 in Greater China
  • 8/29/2025Adcoris Raises CNY Tens of Millions to Advance Next-Gen ADC Programs
  • 8/29/2025MagicRNA Raises ~CNY 100M in Pre-A+ Financing to Advance HN2301 Thera...
  • 8/29/2025D3 Bio's D3S-001 Receives FDA Breakthru Therapy and Orphan Drug Design...
  • 8/29/2025Boehringer's Zongertinib Gains Conditional Approval in China
  • 8/29/2025Hengrui's SHR2554 Receives Conditional NMPA Approval
  • 8/29/2025​​​​​​​CDE Issues Draft Requirements for Module 2 Chemistry Doc...
  • 8/29/2025CDE Issues Technical Guideline for Non-Clinical Research of Vaccine Ad...
  • 8/29/2025CDE Invites Public Comment on 97th Batch of Reference Formulations for...
  • 8/29/2025CDE Solicits Comments on Draft Guideline for Post-Approval Change Mana...
  • 8/29/2025CDE Seeks Comment on ICH E6(R3) GCP Implementation Recommendations
  • 8/29/2025NHSA Announces Results of Form Review for 2025 NRDL Submissions
  • 8/29/2025Akeso Advances First Bispecific ADC Into Clinical Stage With First Pat...
  • 8/27/2025China Pushes for Biopharma-Focused Investment Funds to Accelerate Sect...
  • 8/27/2025Royalty Pharma Targets China's Biotech Market with Early-Stage Investm...
  • 8/27/2025CRO ChemPartner to Open New Boston Research Hub in September
  • Page:3/58 Total number of articles:1735: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group